Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4199]

ASCO 2014: Adjuvant exemestane is more effective than tamoxifen when combined with ovarian function suppression in young women with hormone-sensitive, early-stage breast cancer

ASCO 2014: Adjuvant exemestane is more effective than tamoxifen when combined with ovarian function suppression in...

ASCO 2014: Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early- stage HER2-positive breast cancer

ASCO 2014: Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early- stage HER2-positive breast...

ASCO 2014: LHRH analogue goserelin helps preserve fertility among women undergoing chemotherapy for hormone receptor-negative breast cancer

ASCO 2014: LHRH analogue goserelin helps preserve fertility among women undergoing chemotherapy for hormone...

ASCO 2014: Less frequent zoledronic acid is safe, and has comparable efficacy for women with breast cancer and bone metastases, compared to the standard monthly treatment

ASCO 2014: Less frequent zoledronic acid is safe, and has comparable efficacy for women with breast cancer and...

20 years of the European Institute of Oncology

20 years of the European Institute of Oncology

Guideline update recommends tamoxifen for up to 10 years for women with non-metastatic hormone receptor positive breast cancer

Guideline update recommends tamoxifen for up to 10 years for women with non-metastatic hormone receptor positive...

Pancreatic cancer projected to become second leading cause of cancer-related death in the United States by 2030

Pancreatic cancer projected to become second leading cause of cancer-related death in the United States by 2030

Research in several cancers reveals promising treatment strategies, new insights on screening, and obesity-cancer link

Research in several cancers reveals promising treatment strategies, new insights on screening, and obesity-cancer...

Obesity substantially increases breast cancer mortality only in women with pre-menopausal ER disease

Obesity substantially increases breast cancer mortality only in women with pre-menopausal ER disease

IMPAKT: Molecular subtype of a breast cancer relapse influences patient post-relapse survival

IMPAKT: Molecular subtype of a breast cancer relapse influences patient post-relapse survival

More from ecancer